tiprankstipranks
Trending News
More News >
Clal Biotechnology Industries Ltd (IL:CBI)
:CBI
Israel Market

Clal Biotech (CBI) Financial Statements

Compare
0 Followers

Clal Biotech Financial Overview

Clal Biotech's market cap is currently ₪47.21M. The company's EPS TTM is -0.397; its P/E ratio is -0.78; Clal Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue₪ 433.00K₪ 104.00K₪ 370.00K₪ 224.00K₪ 206.00K
Gross Profit₪ -183.00K₪ 104.00K₪ 370.00K₪ 224.00K₪ 206.00K
Operating Income₪ -6.34M₪ -10.18M₪ -27.42M₪ -77.59M₪ 40.15M
EBITDA₪ -6.34M₪ -24.02M₪ 64.22M₪ -55.08M₪ 13.23M
Net Income₪ -62.46M₪ -31.05M₪ -61.74M₪ -89.58M₪ 109.03M
Balance Sheet
Cash & Short-Term Investments₪ 5.01M₪ 13.36M₪ 12.88M₪ 53.05M₪ 186.50M
Total Assets₪ 67.69M₪ 158.39M₪ 182.69M₪ 444.92M₪ 614.03M
Total Debt₪ 20.84M₪ 35.76M₪ 36.73M₪ 11.68M₪ 7.74M
Net Debt₪ 16.89M₪ 30.03M₪ 1.90M₪ -41.37M₪ -60.42M
Total Liabilities₪ 21.52M₪ 36.98M₪ 37.79M₪ 106.55M₪ 100.24M
Stockholders' Equity₪ 36.63M₪ 99.36M₪ 126.03M₪ 172.59M₪ 306.35M
Cash Flow
Free Cash Flow₪ -6.48M₪ -8.52M₪ -60.31M₪ -42.92M₪ -36.41M
Operating Cash Flow₪ -6.48M₪ -8.51M₪ -59.04M₪ -41.33M₪ -33.23M
Investing Cash Flow₪ 20.00M₪ 7.66M₪ -10.96M₪ 79.18M₪ 70.78M
Financing Cash Flow₪ -15.55M₪ -1.18M₪ 20.05M₪ -51.54M₪ -2.38M
Currency in ILS

Clal Biotech Earnings and Revenue History

Clal Biotech Debt to Assets

Clal Biotech Cash Flow

Clal Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.